CR011-vcMMAE

DRUG2 trials

Sponsors

CuraGen Corporation

Conditions

Breast CancerUnresectable Stage III or Stage IV Melanoma

Phase 1

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

CompletedNCT00412828

CuraGen CorporationUnresectable Stage III or Stage IV Melanoma

Start: 2006-06-30End: 2011-05-31Updated: 2015-02-19

Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer

CompletedNCT00704158

CuraGen CorporationBreast Cancer

Start: 2008-06-30End: 2011-06-30Updated: 2015-02-19